Cipher Surgical Completes $10 Million Series A Funding
Summary
OpClear\xae, the companys flagship device, enhances visibility during minimally invasive surgery by providing continuous lens cleaning, reducing surgical delays and improving patient outcomes.Were thrilled to partner with MSI as we enter this exciting phase of growth, said Mark Alley, CEO of Cipher Surgical. This investment validates the strong clinical demand for improved laparoscopic visualization and positions us to scale our operations globally.MSI brings deep sector expertise and a strong network within the surgical device ecosystem. Cipher Surgicals technology addresses a critical unmet need in the operating room, said Tracy Augustine, MSIs CEO. Its proprietary OpClear\xae technology keeps laparoscopic lenses clean during surgery, enhancing procedural efficiency and patient safety.About Medical Solutions, Inc MSI specializes in high-impact healthcare and medical technology ventures. With a portfolio spanning early-stage and growth companies, MSI partners with innovators to bring transformative solutions to market.